FDA Approves Brainsway’s Deep TMS Depression Treatment Device

On January 7, 2013, the United States Food and Drug Administration (FDA) approved Brainsway’s transcranial magnetic stimulation (TMS) device as a therapy for treatment-resistant depression. The device, called Deep TMS, is approved for adults who fail to respond to antidepressant treatment during a depression episode. The FDA approval enables Brainsway to market the device in the United States. In its January 10, 2013 announcement of the FDA approval, Brainsway said that it was still considering how to market and distribute the Deep TMS device in the United States.

TMS is a noninvasive technique used to . . .